Fingerprint
Dive into the research topics where Craig Adam Kovitz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)☆
Hahn, A. W., Chahoud, J., Skelton, W. P., Yuan, Y., Zurita-Saavedra, A. J., Kovitz, C., Alhalabi, O., Campbell, M. T., Jonasch, E., Lin, J. K., Desai, M., Santos, M. J. M. N., Hwang, H., Corn, P. G., Msaouel, P. & Tannir, N. M., 2025, (Accepted/In press) In: Annals of Oncology.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Sherry, A. D., Siddiqui, B. A., Haymaker, C., Fellman, B. M., Medina-Rosales, M. N., Bathala, T. K., Wang, S., Liu, S., Seo, A., Hara, K., Lu, H., Troncoso, P., Chun, S. G., Ha, C. S., Mayo, L. L., Mok, H., Park, R. J., Chapin, B. F., Phillips, R. M. & Deek, M. P. & 11 others, , Nov 2025, In: European urology. 88, 5, p. 496-509 14 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
Tang, C., Sherry, A. D., Seo, A., Hara, K., Choi, H., Liu, S., Sun, X., Montoya, A., Ludmir, E. B., Shah, A. Y., Jonasch, E., Zurita, A. J., Kovitz, C., Alhalabi, O., Goswami, S., Hahn, A. W., Campbell, M. T., Hernandez, A., Nead, K. T. & Van Loo, P. & 10 others, , Oct 2025, In: The lancet oncology. 26, 10, p. 1289-1299 11 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Scopus citations -
First-line treatment of fecal microbiota transplantation for immune-mediated colitis.
Varatharajalu, K., Shatila, M., Campbell, M. T., Kovitz, C. A., DuPont, H. L. & Wang, Y., Jun 2024, In: Journal of Clinical Oncology. 42, 16, p. 2660 1 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Scopus citations -
Outcomes of patients (pts) with advanced renal cell carcinoma (aRCC) treated with cabozantinib (CABO) after lenvatinib plus pembrolizumab (LEN+PEM)
Haro-Silerio, J. I., Johns, A., Moussa, M. J., Wang, M., Wang, E., Kovitz, C. A., Campbell, M. T., Jonasch, E., Shah, A. Y. & Tannir, N. M., 2024, In: Journal of Clinical Oncology. 42, 4, 433.Research output: Contribution to journal › Article › peer-review